Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(benzhydryloxy)-1-[3-(1H-tetrazol-5-yl)propyl]piperidine
- Development stage
- Unknown
- Lead developer
- Sumitomo Metal Industries
- Modality
- Small Molecules
01
Overview
A synthetic small molecule of the diphenylmethane class, with the chemical formula C22H27N5O and a molecular weight of approximately 377.48 g/mol[2][3][4]. It is also known as HQL‑79 and has been studied primarily as an experimental compound. The main reported mechanism is selective inhibition of hematopoietic prostaglandin D synthase (HPGDS), an enzyme involved in prostaglandin D2 biosynthesis. This target suggests potential utility in modulating allergic or inflammatory responses, but there are no approved indications or advanced clinical trials for this compound[9]. It remains a research tool rather than a developed pharmaceutical.
- Other names
- 4-benzhydryloxy-1-[3-(1H-tetrazol-5-yl)propyl]piperidine4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl]piperidine1-(3-(1H-tetrazol-5-yl)propyl)-4-(benzhydryloxy)piperidinePiperidine, 4-(diphenylmethoxy)-1-[3-(2H-tetrazol-5-yl)propyl]
02
Targets
HPGDS (Haematopoietic prostaglandin D synthase)
Beyond the preview
Go deeper on 4-(benzhydryloxy)-1-[3-(1H-tetrazol-5-yl)propyl]piperidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-(benzhydryloxy)-1-[3-(1H-tetrazol-5-yl)propyl]piperidine.